Wordt geladen...
Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage
BACKGROUND: Severe or massive postpartum hemorrhage (PPH) has remained a leading cause of maternal mortality for decades across the world and it results in critical obstetric complications. Recombinant activated factor VII (rFVIIa) has emerged as a gold standard adjunctive hemostatic agent for the t...
Bewaard in:
| Gepubliceerd in: | Korean J Crit Care Med |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Korean Society of Critical Care Medicine
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6786683/ https://ncbi.nlm.nih.gov/pubmed/31723654 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4266/kjccm.2016.00787 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|